Involvement of PKC delta (PKCδ) in the resistance against different doxorubicin analogs

Breast Cancer Research and Treatment

Volumn 126, Issue 3, 2011, Pages 577-587

  Bessone, María Ines Dìaz ^a   Berardi, Damian E ^a   Campodónico, Paola B ^a   Todaro, Laura B ^a   Lothstein, Leonard ^b   Bal De Kier Joffe, Elisa D ^a   Urtreger, Alejandro J ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

AD 198; AD 288; Cell death resistance; PKC

Indexed keywords

DOXORUBICIN DERIVATIVE; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; N BENZYLDOXORUBICIN; N BENZYLDOXORUBICIN 14 VALERATE; PROTEIN KINASE B; PROTEIN KINASE C DELTA; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; BREAST CELL; CELL LINE; CELL STRAIN NMUMG; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG MECHANISM; DRUG RESISTANCE; ENZYME ACTIVATION; GENE EXPRESSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; DNA TOPOISOMERASES, TYPE II; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION PROFILING; MAMMARY NEOPLASMS, ANIMAL; MICE; NF-KAPPA B; PROTEIN KINASE C-DELTA; PROTO-ONCOGENE PROTEINS C-AKT; SUBCELLULAR FRACTIONS;

EID: 79958741860     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-0956-2     Document Type: Article

References (40)

1. Roaten JB, Kazanietz MG, Sweatman TW et al (2001) Molecular models of N-benzyladriamycin-14-valerate (AD 198) in complex with the phorbol ester-binding C1b domain of protein kinase C-delta. J Med Chem 44:1028-1034 (Pubitemid 32852129)
2. Bilyeu JD, Panta GR, Cavin LG et al (2004) Circumvention of nuclear factor kappaB-induced chemoresistance by cytoplasmic-targeted anthracyclines. Mol Pharmacol 65:1038-1047 (Pubitemid 38420510)
3. Roaten JB, Kazanietz MG, Caloca MJ et al (2002) Interaction of the novel anthracycline antitumor agent N-benzyladriamycin-14-valerate with the C1-regulatory domain of protein kinase C: structural requirements, isoform specificity, and correlation with drug cytotoxicity. Mol Cancer Ther 1:483-492
4. Lothstein L, Rodrigues PJ, Sweatman TW et al (1998) Cytotoxicity and intracellular biotransformation of N-benzyladriamycin-14-valerate (AD 198) are modulated by changes in 14-O-acyl chain length. Anticancer Drugs 9:58-66 (Pubitemid 28088180)
5. Dekker LV, Parker PJ (1994) Protein kinase C - a question of specificity. Trends Biochem Sci 19:73-77 (Pubitemid 24055564)
6. Grossoni VC, Falbo KB, Kazanietz MG et al (2007) Protein kinase C delta enhances proliferation and survival of murine mammary cells. Mol Carcinog 46:381-390 (Pubitemid 46744458)
7. Mellor H, Parker PJ (1998) The extended protein kinase C superfamily. Biochem J 332(Pt 2):281-292 (Pubitemid 28271856)
8. Newton AC (1997) Regulation of protein kinase C. Curr Opin Cell Biol 9:161-167 (Pubitemid 27135982)
9. Newton AC (1995) Protein kinase C: structure, function, and regulation. J Biol Chem 270:28495-28498
10. Brodie C, Blumberg PM (2003) Regulation of cell apoptosis by protein kinase c delta. Apoptosis 8:19-27 (Pubitemid 36133134)
11. Kang Y, Park JS, Kim SH et al (2000) Overexpression of protein kinase C delta represses expression of proliferin in NIH3T3 cells that regulates cell proliferation. Mol Cell Biol Res Commun 4:181-187 (Pubitemid 32298901)
12. Mischak H, Goodnight JA, Kolch W et al (1993) Overexpression of protein kinase C-delta and -epsilon in NIH 3T3 cells induces opposite effects on growth, morphology, anchorage dependence, and tumorigenicity. J Biol Chem 268:6090-6096 (Pubitemid 23099293)
13. Brodie C, Kuperstein I, Acs P et al (1998) Differential role of specific PKC isoforms in the proliferation of glial cells and the expression of the astrocytic markers GFAP and glutamine syn-thetase. Brain Res Mol Brain Res 56:108-117 (Pubitemid 28271667)
14. Harrington EO, Loffler J, Nelson PR et al (1997) Enhancement of migration by protein kinase Calpha and inhibition of proliferation and cell cycle progression by protein kinase Cdelta in capillary endothelial cells. J Biol Chem 272:7390-7397 (Pubitemid 27166450)
15. Vucenik I, Ramakrishna G, Tantivejkul K et al (2005) Inositol hexaphosphate (IP6) blocks proliferation of human breast cancer cells through a PKCdelta-dependent increase in p27Kip1 and decrease in retinoblastoma protein (pRb) phosphorylation. Breast Cancer Res Treat 91:35-45 (Pubitemid 40684937)
16. Cerda SR, Bissonnette M, Scaglione-Sewell B et al (2001) PKC-delta inhibits anchorage-dependent and -independent growth, enhances differentiation, and increases apoptosis in CaCo-2 cells. Gastroenterology 120:1700-1712 (Pubitemid 32523488)
17. Tanaka Y, Gavrielides MV, Mitsuuchi Y et al (2003) Protein kinase C promotes apoptosis in LNCaP prostate cancer cells through activation of p38 MAPK and inhibition of the Akt survival pathway. J Biol Chem 278:33753-33762 (Pubitemid 37553209)
18. Kiley SC, Clark KJ, Duddy SK et al (1999) Increased protein kinase C delta in mammary tumor cells: relationship to transformation and metastatic progression. Oncogene 18:6748-6757
19. McCracken MA, Miraglia LJ, McKay RA et al (2003) Protein kinase C delta is a prosurvival factor in human breast tumor cell lines. Mol Cancer Ther 2:273-281
20. Clark AS, West KA, Blumberg PM et al (2003) Altered protein kinase C (PKC) isoforms in non-small cell lung cancer cells: PKCdelta promotes cellular survival and chemotherapeutic resistance. Cancer Res 63:780-786 (Pubitemid 36231976)
21. Kim D, Chung J (2002) Akt: versatile mediator of cell survival and beyond. J Biochem Mol Biol 35:106-115 (Pubitemid 35216586)
22. Horbinski C, Chu CT (2005) Kinase signaling cascades in the mitochondrion: a matter of life or death. Free Radic Biol Med 38:2-11 (Pubitemid 39626903)
23. Hsieh HL, Wang HH, Wu CY et al (2007) BK-induced COX-2 expression via PKC-delta-dependent activation of p42/p44 MAPK and NF-kappaB in astrocytes. Cell Signal 19:330-340
24. Satoh A, Gukovskaya AS, Nieto JM et al (2004) PKC-delta and-epsilon regulate NF-kappaB activation induced by cholecystokinin and TNF-alpha in pancreatic acinar cells. Am J Physiol Gastrointest Liver Physiol 287:G582-G591 (Pubitemid 39096624)
25. Lu ZG, Liu H, Yamaguchi T et al (2009) Protein kinase Cdelta activates RelA/p65 and nuclear factor-kappaB signaling in response to tumor necrosis factor-alpha. Cancer Res 69:5927-5935
26. Minhajuddin M, Bijli KM, Fazal F et al (2009) Protein kinase C-delta and phosphatidylinositol 3-kinase/Akt activate mammalian target of rapamycin to modulate NF-kappaB activation and intercellular adhesion molecule-1 (ICAM-1) expression in endothelial cells. J Biol Chem 284:4052-4061
27. Naugler WE, Karin M (2008) NF-kappaB and cancer-identifying targets and mechanisms. Curr Opin Genet Dev 18:19-26
28. Van den Broecke C, Vleminckx K, De Bruyne G et al (1996) Morphotypic plasticity in vitro and in nude mice of epithelial mouse mammary cells (NMuMG) displaying an epithelioid (e) or a fibroblastic (f) morphotype in culture. Clin Exp Metastasis 14:282-296 (Pubitemid 26246574)
29. Mazzoni E, Adam A, Bal de Kier Joffe E et al (2003) Immortalized mammary epithelial cells overexpressing protein kinase C gamma acquire a malignant phenotype and become tumorigenic in vivo. Mol Cancer Res 1:776-787 (Pubitemid 37025596)
30. Urtreger AJ, Grossoni VC, Falbo KB et al (2005) Atypical protein kinase C-zeta modulates clonogenicity, motility, and secretion of proteolytic enzymes in murine mammary cells. Mol Carcinog 42:29-39 (Pubitemid 40041483)
31. Owens RB (1974) Glandular epithelial cells from mice: a method for selective cultivation. J Natl Cancer Inst 52:1375-1378
32. Basu A (2003) Involvement of protein kinase C-delta in DNA damage-induced apoptosis. J Cell Mol Med 7:341-350 (Pubitemid 44151685)
33. Lothstein L, Savranskaya L, Barrett CM et al (2006) N-benzy-ladriamycin- 14-valerate (AD 198) activates protein kinase C-delta holoenzyme to trigger mitochondrial depolarization and cytochrome c release independently of permeability transition pore opening and Ca2+ influx. Anticancer Drugs 17:495-502 (Pubitemid 44309965)
34. Griner EM, Kazanietz MG (2007) Protein kinase C and other diacylglycerol effectors in cancer. Nat Rev Cancer 7:281-294 (Pubitemid 46480971)
35. Mauro LV, Grossoni VC, Urtreger AJ et al (2010) PKC delta (PKCd) promotes tumoral progression of human ductal pancreatic cancer. Pancreas 39:31-41
36. Basu A, Akkaraju GR (1999) Regulation of caspase activation and cis-diamminedichloroplatinum(II)-induced cell death by protein kinase C. Biochemistry 38:4245-4251 (Pubitemid 29172183)
37. Gopee NV, He Q, Sharma RP (2003) Fumonisin B1-induced apoptosis is associated with delayed inhibition of protein kinase C, nuclear factor-kappaB and tumor necrosis factor alpha in LLC-PK1 cells. Chem Biol Interact 146:131-145 (Pubitemid 37323877)
38. Grossoni VC, Falbo KB, Mauro LV et al (2007) Protein kinase C delta inhibits the production of proteolytic enzymes in murine mammary cells. Clin Exp Metastasis 24:513-520 (Pubitemid 47524809)
39. Barrett CM, Lewis FL, Roaten JB et al (2002) Novel extranu-clear-targeted anthracyclines override the antiapoptotic functions of Bcl-2 and target protein kinase C pathways to induce apoptosis. Mol Cancer Ther 1:469-481
40. Lothstein L, Israel M Sweatman TW (2001) Anthracycline drug targeting: cytoplasmic versus nuclear - a fork in the road. Drug Resist Updat 4:169-177 (Pubitemid 33089454)